Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease

Webber Chan^*, Nicole Lynch, Peter Bampton, Jeff Chang, Alvin Chung, Timothy Florin, David J. Hetzel, Simon Jakobovits, Gregory Moore, Paul Pavli, Graham Radford-Smith, Lena Thin, Brandon Baraty, Craig Haifer, Yunki Yau, Rupert W. L. Leong

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review